Detalles de la búsqueda
1.
Very low dose glucocorticoid therapy in rheumatoid arthritis: Impact of b/tsDMARDs initiation timing on glucocorticoid withdrawal.
Rheumatology (Oxford)
; 2024 Feb 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38310364
2.
The SLE-DAS provides an accurate and feasible flare tool in the clinical setting: a validation study.
Rheumatology (Oxford)
; 63(4): 1123-1129, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37458482
3.
Therapeutic Strategies and Outcomes in Neuropsychiatric Systemic Lupus Erythematosus: An International Multicenter Retrospective Study.
Rheumatology (Oxford)
; 2024 Feb 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38402539
4.
Early characterization of difficult-to-treat rheumatoid arthritis by suboptimal initial management: a multicentre cohort study.
Rheumatology (Oxford)
; 62(6): 2083-2089, 2023 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36190344
5.
Systemic lupus erythematosus incidence and prevalence in a large population-based study in northeastern Italy.
Rheumatology (Oxford)
; 62(8): 2773-2779, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36495204
6.
Antiphospholipid antibody carriers and patients with quiescent antiphospholipid syndrome show persistent subclinical complement activation.
Rheumatology (Oxford)
; 2023 Sep 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37774001
7.
New onset and flare of rheumatic diseases following COVID-19 vaccination are mild and respond well to treatment: 9-month follow-up data from a single centre cohort.
Clin Exp Rheumatol
; 41(3): 642-648, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35930472
8.
Anti-MDA5 dermatomyositis: an update from bench to bedside.
Curr Opin Rheumatol
; 34(6): 365-373, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36094462
9.
Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis.
Rheumatology (Oxford)
; 61(2): 688-695, 2022 02 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909900
10.
High plasma C5a and C5b-9 levels during quiescent phases are associated to severe antiphospholipid syndrome subsets.
Clin Exp Rheumatol
; 40(11): 2088-2096, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-35238757
11.
Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) enables accurate and user-friendly definitions of clinical remission and categories of disease activity.
Ann Rheum Dis
; 80(12): 1568-1574, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34407927
12.
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort.
J Autoimmun
; 124: 102729, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34600347
13.
Prevalence, outcome and management of patients with SLE and secondary antiphospholipid antibody syndrome after aPL seroconversion.
Rheumatology (Oxford)
; 60(3): 1313-1320, 2021 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32940703
14.
Baseline characteristics of systemic lupus erythematosus patients included in the Lupus Italian Registry of the Italian Society for Rheumatology.
Lupus
; 30(8): 1233-1243, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33884900
15.
Remission in systemic lupus erythematosus: testing different definitions in a large multicentre cohort.
Ann Rheum Dis
; 79(7): 943-950, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32321721
16.
Prevalence and predictors of flare after immunosuppressant discontinuation in patients with systemic lupus erythematosus in remission.
Rheumatology (Oxford)
; 59(7): 1591-1598, 2020 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31642908
17.
Derivation and validation of the SLE Disease Activity Score (SLE-DAS): a new SLE continuous measure with high sensitivity for changes in disease activity.
Ann Rheum Dis
; 78(3): 365-371, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30626657
18.
Lupus low disease activity state is associated with a decrease in damage progression in Caucasian patients with SLE, but overlaps with remission.
Ann Rheum Dis
; 77(1): 104-110, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-28970217
19.
Changing patterns in clinical-histological presentation and renal outcome over the last five decades in a cohort of 499 patients with lupus nephritis.
Ann Rheum Dis
; 77(9): 1318-1325, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29730634
20.
Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study.
J Autoimmun
; 86: 1-8, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28935492